Journal of Advanced Biomedical Sciences
JABS
Thu, May 14, 2026
[
Archive
]
Remember me
Create Account
Reset Password
Home
Journal Information
About Journal
Aims & Scope
Editorial Board
Peer Review Process
Publication Ethics
Transparency Statement
Indexing & Abstracting
Journal News
Issues
All Issues
Current Issue
For Authors
Call for Papers
Submission Instruction
Submission Form
For Reviewers
Reviewers Section
Registration
Registration Information
Registration Form
Contact us
Contact Information
Contact us
Search published articles
Showing 1 results for Anti-Ccp
Association between Anti-Citrullinated Peptide Antibodies (ACPA) Levels and Disease Severity in Patients with Rheumatoid Arthritis
Poopak Mohaghegh, Mohammad Sadegh Ghasempuor, Azizallah Dehghan,
Volume 16, Issue 1 (1-2026)
Abstract
Background & Objectives:
This case–control study was conducted to assess the diagnostic accuracy of serum anti-cyclic citrullinated peptide (anti-CCP) antibodies in rheumatoid arthritis (RA) and to determine their correlation with disease activity, as measured by the Disease Activity Score in 28 joints using C-reactive protein (DAS28-CRP).
Materials & Methods:
A total of
70 patients with RA (85.7% female; mean age = 55.7 ± 11.73 years) and 70 age- and sex-matched healthy controls were included. Serum anti-CCP levels were measured using an enzyme-linked immunosorbent assay (ELISA), and disease activity was evaluated based on DAS28-CRP scores. Pearson’s correlation coefficient was applied to assess the relationship between anti-CCP levels and RA disease activity.
Results:
Anti-CCP exhibited a sensitivity of 61.4% and a specificity of 98.6% for the diagnosis of RA. The mean serum anti-CCP concentration was significantly elevated in RA patients (220.2 ± 27.5 IU/mL) compared with controls (1.57 ± 0.52 IU/mL; p < 0.001). However, no statistically significant correlation was observed between anti-CCP levels and disease activity as determined by DAS28-CRP (p = 0.4).
Conclusion:
Anti-CCP is a highly specific serological biomarker for the diagnosis of RA but does not demonstrate a significant association with disease activity as measured by DAS28-CRP. Further large-scale, longitudinal investigations are warranted to elucidate its potential role in predicting long-term joint destruction and disease progression.
Page
1
from
1
This work is licensed under a
Creative Commons — Attribution-NonCommercial 4.0 International
(CC BY-NC 4.0)